Bristol-Myers Squibb (BMY) Investor Meeting Feedback Comments From Jefferies

September 27, 2017 7:54 AM EDT Send to a Friend
Jefferies maintains Buy on Bristol-Myers Squibb Co. (NYSE: BMY) price target of $72.00.Analyst Jeff Holford says business development remains a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login